BEAM
Beam Therapeutics Inc
NASDAQ · Biotechnology
$26.52
+1.79 (+7.24%)
Performance
1D
—
1W
-5.01%
1M
-21.28%
3M
+17.97%
6M
+51.37%
1Y
-0.19%
YTD
-2.28%
Open$25.63
Previous Close$24.73
Day High$26.68
Day Low$25.21
52W High$36.44
52W Low$13.53
Volume1.35M
Avg Volume1.53M
Market Cap2.69B
P/E Ratio—
EPS$-4.43
SectorBiotechnology
Volume Analysis
0.88x average volume
Technical Indicators
SMA 50
$28.23
Below
SMA 200
$22.40
Above
RSI (14)
35.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
23 analysts
Price Target
+134.0% upside
Current
$26.52
$26.52
Target
$62.07
$62.07
$37.88
$62.07 avg
$80.69
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 78.31M | 73.18M | 539.73M |
| Net Income | -464,440,668 | -390,614,523 | -53,413,528 |
| Profit Margin | -593.1% | -563.5% | -9.9% |
| EBITDA | -483,315,008 | -429,071,355 | -41,391,154 |
| Free Cash Flow | — | — | -43,209,591 |
| Rev Growth | +7.0% | +7.0% | -3.6% |
| Debt/Equity | — | — | 0.17 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |